Cargando…
Rho GTPase-activating protein 35 suppresses gastric cancer metastasis by regulating cytoskeleton reorganization and epithelial-to-mesenchymal transition
Cytoskeletal reorganization and epithelial-to-mesenchymal transition (EMT) are key processes and typical characteristics of metastatic cancer cells. Rho GTPase‑activating protein 35 (ARHGAP35) is a GTPase-activating protein, which has a significant effect on cell motility. However, the particular fu...
Autores principales: | Sun, Yi, Du, Rui, Shang, Yulong, Liu, Changhao, Zheng, Linhua, Sun, Ruiqing, Wang, Yuanyong, Lu, Guofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342288/ https://www.ncbi.nlm.nih.gov/pubmed/35758029 http://dx.doi.org/10.1080/21655979.2022.2092677 |
Ejemplares similares
-
Arf GTPase interplay with Rho GTPases in regulation of the actin cytoskeleton
por: Singh, Vikash, et al.
Publicado: (2017) -
The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
por: Qin, Cheng-Dong, et al.
Publicado: (2018) -
Expression of Rho GTPases family in melanoma cells and its influence on cytoskeleton and migration
por: Wen, Si-Jian, et al.
Publicado: (2017) -
Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis
por: Kim, Chan, et al.
Publicado: (2016) -
Small Rho-GTPases and cortical malformations: Fine-tuning the cytoskeleton stability
por: Cappello, Silvia
Publicado: (2013)